| Financial Year |
March 31 2023 |
| Monetary Funds |
5,611,391,222.95 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
39,711,955.65 |
| Advances to Suppliers |
94,894,442.03 |
| Other Receivables |
1,682,430,073.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
31,799,432,904.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,882,630,419.25 |
| Total Current Assets |
41,110,491,018.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
428,239,980.61 |
| Investment Properties |
340,917,794.68 |
| Fixed Assetes |
1,623,738,848.56 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,797,512.92 |
| R&D expenses |
-- |
| Goodwill |
41,593,308.69 |
| Long-Term Deferred and Prepaid Expenses |
2,378,699.71 |
| Deferred Income Tax Assets |
306,235,250.74 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,207,408,650.47 |
| Total Assets |
44,317,899,668.68 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,183,850,231.02 |
| Accounts Received In Advance |
51,983,383.66 |
| Employee Compensation Payable |
5,588,320.26 |
| Taxes Payable |
702,024,522.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,110,971,261.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,641,125,888.39 |
| Other Current Liabilities |
1,238,341,786.45 |
| Sub-Total of Current Liabilities |
30,486,519,233.97 |
| Long-term Loans |
3,194,162,640.46 |
| Bonds Payable |
4,365,362,737.01 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
13,220,460.51 |
| Deferred Income Tax Liabilities |
104,290,576.61 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,011,111,746.10 |
| Total Liabilities |
38,497,630,980.07 |
| Paid-In Capital(Or Share Stock) |
2,346,100,874.00 |
| Capital Surplus |
1,276,771,189.34 |
| Surplus Reserve |
411,946,384.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-737,011,683.66 |
| Minority Stockholder's Interest |
-326,588,075.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,146,856,764.13 |
| Owner's Equity（Stockholder's Equity） |
5,820,268,688.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
44,317,899,668.68 |
